TWINRIX 720 [iU]/mL
Hepatitis A and Hepatitis B (Recombinant) Vaccine · INJECTION, SUSPENSION · GlaxoSmithKline Biologicals SA
TWINRIX is a injection, suspension containing hepatitis a and hepatitis b (recombinant) vaccine at 720 [iU]/mL, taken intramuscular. Manufactured by GlaxoSmithKline Biologicals SA.
Key Facts
- Brand Name
- TWINRIX
- Generic Name
- Hepatitis A and Hepatitis B (Recombinant) Vaccine
- NDC Code (Product)
58160-815- Manufacturer
- GlaxoSmithKline Biologicals SA
- Strength
- 720 [iU]/mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA103850
- Marketing Start
- 06/07/2007
Recall History
No Recall HistoryFrequently Asked Questions
What is TWINRIX used for?
TWINRIX contains Hepatitis A and Hepatitis B (Recombinant) Vaccine. It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is TWINRIX a controlled substance?
TWINRIX is not classified as a controlled substance by the DEA.
What is the generic name for TWINRIX?
The generic name for TWINRIX is Hepatitis A and Hepatitis B (Recombinant) Vaccine. There are no other listed brand versions of Hepatitis A and Hepatitis B (Recombinant) Vaccine.
What is the NDC code for TWINRIX 720 [iU]/mL?
The NDC (National Drug Code) for TWINRIX 720 [iU]/mL is 58160-815, listed by GlaxoSmithKline Biologicals SA.
Other TWINRIX Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)